For the month ended 31 March 2026, Clarity Medical Group Holding Limited recorded no changes in either authorised or issued share capital. Authorised capital remained at 5.00 billion ordinary shares with a par value of HKD 0.01, equivalent to HKD 50.00 million.

Issued shares were unchanged at 536.33 million, and the company held no treasury shares. As a result, the public float continued to meet the Main Board’s 25 percent minimum requirement.

There were no share options, warrants, or convertible securities exercised or issued during the period. The previously adopted pre-IPO share option scheme showed zero outstanding options, confirming its inactivity. Separately, the company’s share award plan—approved on 23 November 2022—still permits the future issuance of up to 43.97 million shares, although no awards were granted in March.

The board affirmed that all regulatory and listing rule obligations were satisfied during the reporting period, with no new fund-raising activities undertaken.